Skip to main content

Table 4 Comparison of microfluidic POCT devices for molecular diagnostics

From: Microfluidics-based strategies for molecular diagnostics of infectious diseases

Approval time

Devices

Manufacturers

Regulator

Detection technology

Targets

LOD

Detection time

References

2007.08

Unyvero A50

Curetis

CE

Multiplex PCR

Hospitalized pneumonia, blood culture, intra-abdominal infection, urinary tract infection, implant & tissue infection

–

< 5 h

[199]

2007.09

Verigene®

Nanosphere

FDA

RT-PCR

C. diff, enteric pathogens, respiratory pathogens, Gram bacteria

–

2–2.5 h

[202]

2010.05

Simplexaâ„¢

Focus Diagnostics

FDA

RT-PCR

SARS-CoV-2, influenza A/B & RSV, HSV 1 & 2, influenza A, H1N1

242–500 copies/ml

< 80 min

[182]

2011.08

Cobas® Liat®

Roche

FDA

Multiplex real-time RT-PCR

SARS-CoV-2, influenza A/B, RSV, Cdiff and strep A

10–3–10–1 TCID50/ml

< 20 min

[186]

2012.01

BD MAXâ„¢

BD

FDA

RT-PCR

GBS, MRSA, C. diff, SA, vaginal pathogens, enteric bacterial and parasite, CT/GC/TV

–

45–90 min

[197]

2012.11

GeneXpert® Infinity Systems

Cepheid

FDA

RT-PCR

GBS, MRSA, gastrointestinal pathogens, MTB, TV, respiratory viruses and so on

–

–

[198]

2013.02

FilmArray® Biofire®

Biofire

FDA

Nested Multiplex PCR

Respiratory, blood, gastrointestinal and meningitis infection and so on

1000 TCID50/ml

45–60 min

[174]

2014

Idyllaâ„¢

Biocartis

CE

RT-PCR

BRAF, KRAS, NRAS, EGFR genes

–

90–180 min

[194]

2015

Alereâ„¢ Q

Abbott

CE

RT-PCR

HIV

–

< 52 min

[193]

2016.02

IO single module system

Binx health

CE

PCR

CT, NG and so on

–

< 30 min

[191, 192]

2017.05

Revogene®

GenePOC

FDA

RT-PCR

C. diff, GBS, GAS and CRE

–

< 70 min

[200]

2017.06

ePlex

GenMark

FDA

RT-PCR

Bloodstream infections and respiratory pathogens

–

< 90 min

[201]

2017.07

RTisochipâ„¢-A

CapitalBio Technology

NMPA

Isothermal amplification

19 respiratory viruses and 8 pathogenic bacteria

10–103 copies/run

< 50 min

[177]

2018.09

iChip-400

Baicare

NMPA

LAMP

16 pathogenic bacteria

–

< 1 h

[195]

2018.11

GenPlex®

BOHUI

NMPA

Multiplex PCR

24 HPV and 18 respiratory viruses

–

–

[175]

2019.07

RTisochipâ„¢-W

CapitalBio Technology

NMPA

NASBA

19 respiratory viruses and 8 pathogenic bacteria

50 copies/run

20–50 min

[178, 179]

2020.01

WizDxâ„¢ F-150 Real-time PCR System

Wizbiosolutions

CE

Ultra-fast RT-PCR

SARS-CoV-2

20 copies/run

< 40 min

[190]

2021.01

Onestart-1000

Baicare

NMPA

RT-PCR

60 pathogenic bacteria

103 copies/ml

< 1.5 h

[196]

2021.02

DxLab-2A

CapitalBio Technology

NMPA

Nested PCR

SARS-CoV-2

500 copies/ml

< 45 min

[180]

2021.03

Cueâ„¢

Cue health

FDA

Isothermal amplification

SARS-CoV-2

20 copies/test

20 min

[181]

2021.06

iGeneTec MA3000

Superchip technology

NMPA

Isothermal amplification

SARS-CoV-2

500 copies/ml

< 45 min

[187]

2021.08

Visby Medicalâ„¢

Visby Medical

FDA

PCR

SARS-CoV-2, chlamydia, NG, TV

–

< 30 min

[189]

–

Vivalytic

BOSCH, Randox

–

End-point PCR

Respiratory and sexually transmitted infections viruses

–

30–150 min

[176]

–

QuanPLEX

IntelliBio

–

qPCR

7 respiratory viruses

–

–

[183]

–

AriaDNA

Lumex Instruments

–

RT-PCR

SARS-CoV-2, african swine fever, cattle pathogens, fish pathogens and avian pathogens

9000 copies/ml

< 50 min

[184]

–

Novodiag®

Mobidiag

–

RT-PCR

SARS-CoV-2, C. diff, enteric pathogens and so on

–

< 1 h

[185]

–

BINAS

Tsinghua University

–

Nested isothermal amplification

SARS-CoV-2

< 400 copies/ml

< 30 min

[188]

  1. "–" means the information is not officially available from public data or is too complicated to be noted; LOD limits of detection, NMPA national medical products administration; CE conformite europeenne, FDA U.S. Food & Drug Administration, C. diff Clostridium difficile, CRE Carbapenem-resistant Enterobacteriaceae, GAS Group A streptococcus; GBS Group B streptococcus, HPV human papilloma virus, HSV herpes simplex virus, MRSA methicillin-resistant Staphylococcus aureus, MTB Mycobacterium tuberculosis, NG Neisseria gonorrhoeae, RSV respiratory syncytial virus, SA Staphylococcus aureus, TV Trichomonas vaginalis, SARS-CoV-2 severe acute respiratory syndrome coronavirus 2, PCR polymerase chain reaction, qPCR quantitative real-time polymerase chain reaction, LAMP loop-mediated isothermal amplification, RT-PCR reverse-transcription polymerase chain reaction, NASBA nucleic acid sequence-based amplification, TCID50 50% tissue culture infective dose